These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 9162067

  • 1. Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120(CBL) and p110(HEF1).
    Sattler M, Salgia R, Shrikhande G, Verma S, Uemura N, Law SF, Golemis EA, Griffin JD.
    J Biol Chem; 1997 May 30; 272(22):14320-6. PubMed ID: 9162067
    [Abstract] [Full Text] [Related]

  • 2. The adapter protein Crkl links Cbl to C3G after integrin ligation and enhances cell migration.
    Uemura N, Griffin JD.
    J Biol Chem; 1999 Dec 31; 274(53):37525-32. PubMed ID: 10608804
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-2 stimulation induces tyrosine phosphorylation of p120-Cbl and CrkL and formation of multimolecular signaling complexes in T lymphocytes and natural killer cells.
    Gesbert F, Garbay C, Bertoglio J.
    J Biol Chem; 1998 Feb 13; 273(7):3986-93. PubMed ID: 9461587
    [Abstract] [Full Text] [Related]

  • 4. BCR/ABL-induced leukemogenesis causes phosphorylation of Hef1 and its association with Crkl.
    de Jong R, van Wijk A, Haataja L, Heisterkamp N, Groffen J.
    J Biol Chem; 1997 Dec 19; 272(51):32649-55. PubMed ID: 9405482
    [Abstract] [Full Text] [Related]

  • 5. p130CAS forms a signaling complex with the adapter protein CRKL in hematopoietic cells transformed by the BCR/ABL oncogene.
    Salgia R, Pisick E, Sattler M, Li JL, Uemura N, Wong WK, Burky SA, Hirai H, Chen LB, Griffin JD.
    J Biol Chem; 1996 Oct 11; 271(41):25198-203. PubMed ID: 8810278
    [Abstract] [Full Text] [Related]

  • 6. Association of the Cas-like molecule HEF1 with CrkL following integrin and antigen receptor signaling in human B-cells: potential relevance to neoplastic lymphohematopoietic cells.
    Astier A, Manié SN, Law SF, Canty T, Haghayghi N, Druker BJ, Salgia R, Golemis EA, Freedman AS.
    Leuk Lymphoma; 1997 Dec 11; 28(1-2):65-72. PubMed ID: 9498705
    [Abstract] [Full Text] [Related]

  • 7. The BCR/ABL oncogene alters interaction of the adapter proteins CRKL and CRK with cellular proteins.
    Uemura N, Salgia R, Li JL, Pisick E, Sattler M, Griffin JD.
    Leukemia; 1997 Mar 11; 11(3):376-85. PubMed ID: 9067577
    [Abstract] [Full Text] [Related]

  • 8. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E, Xu G, Li JL, Prasad KV, Griffin JD.
    Oncogene; 1996 Feb 15; 12(4):839-46. PubMed ID: 8632906
    [Abstract] [Full Text] [Related]

  • 9. Differential interaction of Crkl with Cbl or C3G, Hef-1, and gamma subunit immunoreceptor tyrosine-based activation motif in signaling of myeloid high affinity Fc receptor for IgG (Fc gamma RI).
    Kyono WT, de Jong R, Park RK, Liu Y, Heisterkamp N, Groffen J, Durden DL.
    J Immunol; 1998 Nov 15; 161(10):5555-63. PubMed ID: 9820532
    [Abstract] [Full Text] [Related]

  • 10. Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL).
    Sattler M, Salgia R, Shrikhande G, Verma S, Pisick E, Prasad KV, Griffin JD.
    J Biol Chem; 1997 Apr 11; 272(15):10248-53. PubMed ID: 9092574
    [Abstract] [Full Text] [Related]

  • 11. Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins.
    Barber DL, Mason JM, Fukazawa T, Reedquist KA, Druker BJ, Band H, D'Andrea AD.
    Blood; 1997 May 01; 89(9):3166-74. PubMed ID: 9129019
    [Abstract] [Full Text] [Related]

  • 12. Alpha 4 beta 1 integrin-mediated tyrosine phosphorylation in human T cells: characterization of Crk- and Fyn-associated substrates (pp105, pp115, and human enhancer of filamentation-1) and integrin-dependent activation of p59fyn1.
    Hunter AJ, Shimizu Y.
    J Immunol; 1997 Nov 15; 159(10):4806-14. PubMed ID: 9366405
    [Abstract] [Full Text] [Related]

  • 13. Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells.
    Bhat A, Kolibaba K, Oda T, Ohno-Jones S, Heaney C, Druker BJ.
    J Biol Chem; 1997 Jun 27; 272(26):16170-5. PubMed ID: 9195915
    [Abstract] [Full Text] [Related]

  • 14. Involvement of p130(Cas) and p105(HEF1), a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells.
    Manié SN, Beck AR, Astier A, Law SF, Canty T, Hirai H, Druker BJ, Avraham H, Haghayeghi N, Sattler M, Salgia R, Griffin JD, Golemis EA, Freedman AS.
    J Biol Chem; 1997 Feb 14; 272(7):4230-6. PubMed ID: 9020138
    [Abstract] [Full Text] [Related]

  • 15. Differential expression and signaling of CBL and CBL-B in BCR/ABL transformed cells.
    Sattler M, Pride YB, Quinnan LR, Verma S, Malouf NA, Husson H, Salgia R, Lipkowitz S, Griffin JD.
    Oncogene; 2002 Feb 21; 21(9):1423-33. PubMed ID: 11857085
    [Abstract] [Full Text] [Related]

  • 16. Role of the adapter protein CRKL in signal transduction of normal hematopoietic and BCR/ABL-transformed cells.
    Sattler M, Salgia R.
    Leukemia; 1998 May 21; 12(5):637-44. PubMed ID: 9593259
    [Abstract] [Full Text] [Related]

  • 17. Stimulation through the T cell receptor induces Cbl association with Crk proteins and the guanine nucleotide exchange protein C3G.
    Reedquist KA, Fukazawa T, Panchamoorthy G, Langdon WY, Shoelson SE, Druker BJ, Band H.
    J Biol Chem; 1996 Apr 05; 271(14):8435-42. PubMed ID: 8626543
    [Abstract] [Full Text] [Related]

  • 18. All-trans-retinoic acid induces tyrosine phosphorylation of the CrkL adapter in acute promyelocytic leukemia cells.
    Alsayed Y, Modi S, Uddin S, Mahmud N, Druker BJ, Fish EN, Hoffman R, Platanias LC.
    Exp Hematol; 2000 Jul 05; 28(7):826-32. PubMed ID: 10907644
    [Abstract] [Full Text] [Related]

  • 19. The two major sites of cbl tyrosine phosphorylation in abl-transformed cells select the crkL SH2 domain.
    Andoniou CE, Thien CB, Langdon WY.
    Oncogene; 1996 May 02; 12(9):1981-9. PubMed ID: 8649859
    [Abstract] [Full Text] [Related]

  • 20. Structural requirements for function of the Crkl adapter protein in fibroblasts and hematopoietic cells.
    Senechal K, Heaney C, Druker B, Sawyers CL.
    Mol Cell Biol; 1998 Sep 02; 18(9):5082-90. PubMed ID: 9710592
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.